Antipyretic effect of Ayurveda compound on fever in children

A single arm clinical trial to evaluate the antipyretic effect of febrikid tablets in febrile children

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/03/041337

Enrollment

150

Registered

2022-03-24

Start date

Unknown

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B999- Unspecified infectious disease

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient of either gender suffering from fever of age 5 to 12 years 2) Acute onset fever of 1 to 3 days 3) Temperature between 99 to 103 Fahrenheit 4) Children with parents who agree to participate and sign the informed consent

Exclusion criteria

Exclusion criteria: 1) Fever more than 103 Fahrenheit 2) Any febrile condition of children requiring an immediate intervention depending on history and general condition at the point of examination as found by the investigator will be excluded from study

Design outcomes

Primary

Measure	Time frame
Reduction in Fever and body temperature Reduction in body ache and headache improvement in appetiteTimepoint: At base line On Day 2 Day 3 Day 5	—

Secondary

Measure	Time frame
improvement in Leg cramps Improvement in weaknessTimepoint: 5 days 7 days 10 days	—

Countries

India

Contacts

Public ContactDr Shraddha Detroja

Parul Institute of Ayurved

neonatecare99@gmail.com

Outcome results